Kendle

Jeffrey M. Zucker has been appointed senior director and global head of patient recruitment at Kendle. Mr. Zucker will provide global leadership for the development and implementation of innovative strategies to accelerate patient recruitment, improve retention and support the timely and efficient delivery of Phase I-IV clinical development programs for the company’s biopharmaceutical customers.

“Patient recruitment is at the core of the clinical development process,” said Stephen Cutler, Ph.D., senior vice president and chief operating officer. “Finding the right patients for the right studies and keeping them engaged throughout is essential to producing sound clinical research. Jeff’s extensive management experience across many facets of the biopharmaceutical industry will be a great asset for our customers and we are pleased to welcome him to Kendle.”

Mr. Zucker has 15 years of clinical development and management experience. Most recently, he led global trial optimization efforts for Merck & Co. He also has served as director of inpatient operations at CRI Worldwide and as founder and president of Applied Research Trials. Additionally, he held leadership positions for Eli Lilly, Princeton Biomedical Research and multiple clinical investigative sites.